Skip to Content
Merck
CN
  • Efficacy and safety of a new monophasic hyaluronic acid filler in the correction of nasolabial folds: a randomized, evaluator-blinded, split-face study.

Efficacy and safety of a new monophasic hyaluronic acid filler in the correction of nasolabial folds: a randomized, evaluator-blinded, split-face study.

The Journal of dermatological treatment (2013-06-25)
Do Young Rhee, Chong Hyun Won, Sung Eun Chang, Tai Kyung Noh, Myoung Shin Kim, Beom Joon Kim, Gyeong Hun Park, Jee Soo An, Mi Woo Lee, Jee Ho Choi, Kee Chan Moon, Sung Hoon Lim
ABSTRACT

Hyaluronic acid (HA) fillers are frequently used for the correction of facial soft-tissue defects. To compare the efficacy and safety of a novel monophasic HA filler (mono-HA), and a well-studied biphasic HA filler (bi-HA), in the treatment of moderate to severe nasolabial folds. In this randomized, evaluator-blinded, split-face comparative study, subjects were randomized for injections with mono-HA or bi-HA on the left or right side of the face. Efficacy was determined by calculating the change in the Wrinkle Severity Rating Score (WSRS) relative to baseline. Local safety was assessed on the basis of subject diary entries which recorded erythema, swelling, induration, pruritus, irritation, mass, hematoma, pain, and dryness. At week 24, the mean improvement in the WSRS from baseline was 2.18 ± 0.42 for the mono-HA side and 2.16 ± 0.41 for the bi-HA side. Both fillers were well-tolerated and adverse reactions were mild and transient in most cases. Mono-HA has a non-inferior efficacy to bi-HA in the treatment of moderate to severe nasolabial folds.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Hyaluronic acid sodium salt from bovine vitreous humor
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus zooepidemicus, bacterial glycosaminoglycan polysaccharide
Sigma-Aldrich
Hyaluronic acid sodium salt from rooster comb, avian glycosaminoglycan polysaccharide
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, bacterial glycosaminoglycan polysaccharide
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 150,000-300,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 750,000-1,000,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,750,000-2,000,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 90,000-110,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 130,000-150,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,250,000-1,500,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 2,000,000-2,200,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 15,000-30,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,200
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,500,000-1,750,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 8,000-15,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,000,000-1,250,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 30,000-50,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 120,000-350,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 50,000-70,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 2,000,000-2,400,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 10,000-30,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 300,000-500,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 70,000-120,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 500,000-750,000